Preliminary results of a phase I/II study of the humanized anti-CD20 antibody IMMU-106 (hA20) in patients with relapsed non-Hodgkin lymphoma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL LYMPHOMA & MYELOMA | 2007年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：339 / 341
页数：3
相关论文
共 50 条
  • [21] Characterization of new, chimeric and humanized, anti-CD20 monoclonal antibodies, cA20 and hA20, with equivalent efficacy to rituximab in-vitro and in xenografted human non-Hodgkin's lymphoma.
    Goldenberg, DM
    Li, XG
    Qu, ZX
    Stein, R
    Horak, ID
    Hansen, HJ
    [J]. BLOOD, 2002, 100 (11) : 575A - 576A
  • [22] Characterization of a Novel Humanized Anti-CD20 Antibody with Potent Anti-Tumor Activity against Non-Hodgkin's Lymphoma
    Zhang, Haifeng
    Song, Liping
    Ye, Hongtu
    Hu, Lide
    Liang, Wenlu
    Liu, Datao
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 32 (03) : 645 - 654
  • [23] Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
    Tobinai, Kensei
    Ogura, Michinori
    Kobayashi, Yukio
    Uchida, Toshiki
    Watanabe, Takashi
    Oyama, Takashi
    Maruyama, Dai
    Suzuki, Tatsuya
    Mori, Masakazu
    Kasai, Masanobu
    Cronier, Damien
    Wooldridge, James E.
    Koshiji, Minori
    [J]. CANCER SCIENCE, 2011, 102 (02) : 432 - 438
  • [24] Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma
    Yuen, Sam
    Phillips, Tycel J.
    Bannerji, Rajat
    Marlton, Paula
    Gritti, Giuseppe
    Seymour, John F.
    Johnston, Anna
    Arthur, Christopher
    Dodero, Anna
    Sharma, Sunil
    Hirata, Jamie
    Musick, Lisa
    Flowers, Christopher R.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1281 - 1289
  • [25] Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with Zevalin, a 90Y-labeled anti-CD20 monoclonal antibody
    Wiseman, GA
    White, CA
    Witzig, TE
    Gordon, LI
    Emmanouilides, C
    Raubitschek, A
    Janakiraman, N
    Gutheil, J
    Schilder, RJ
    Spies, S
    Silverman, DHS
    Grillo-López, AJ
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3281S - 3286S
  • [26] The Type II Glycoengineered Humanized Anti-CD20 Monoclonal Antibody MIL62 Combined with Orelabrutinib in Chinese Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: Updated Results of a Multicenter, Phase I/IIa Trial
    Shi, Yuankai
    Qin, Yan
    Zang, Aimin
    Li, Yufu
    Yang, Yanli
    Hui Liu
    Gao, Sujun
    Wang, Xinghe
    Zhang, Weijing
    Jin, Zhengming
    Hui Zhou
    Wang Hua-Qing
    Min Wei
    [J]. BLOOD, 2022, 140 : 9482 - 9483
  • [27] Phase I study of a novel humanized anti-CD20 antibody, BM-ca, in patients (pts) with relapsed or refractory indolent B-cell non-Hodgkin lymphoma (B-NHL) pretreated with rituximab
    Tobinai, Kensei
    Ogura, Michinori
    Maruyama, Dai
    Suzuki, Tatsuya
    Kobayashi, Yukio
    Uchida, Toshiki
    Fukuhara, Suguru
    Oyama, Takashi
    Fukuzaki, Tomoharu
    Komatsu, Yasuhiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Radioimmunotherapy with iodine-131 anti-CD20 chimeric monoclonal antibody (rituximab) for relapsed or refractory indolent non-Hodgkin's lymphoma: Results of an Australian phase II trial
    Leahy, MF
    Seymour, JF
    Hicks, RJ
    Turner, JH
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 155 - 156
  • [29] Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma
    Witzig, Thomas E.
    Tomblyn, Michael B.
    Misleh, Jamal G.
    Kio, Ebenezer A.
    Sharkey, Robert M.
    Wegener, William A.
    Goldenberg, David M.
    [J]. HAEMATOLOGICA, 2014, 99 (11) : 1738 - 1745
  • [30] Anti-CD20 monoclonal antibody (Rituximab) in gastric extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients: Clinical and biological results (Phase II study).
    Martinelli, G
    Laszlo, D
    Conconi, A
    Rabascio, C
    Ferreri, AJ
    Pruneri, G
    Crosta, C
    Ponzoni, M
    Pedrinis, E
    Agazzi, A
    Zucca, E
    [J]. BLOOD, 2003, 102 (11) : 410A - 410A
12345